Associated Papers
Targeted transcriptome analysis using synthetic long read sequencing uncovers isoform reprograming in the progression of colon cancer.
Liu S et al.
Communications Biology, 2021
Cross-talk between ANGPTL4 gene SNP Rs1044250 and weight management is a risk factor of metabolic syndrome.
Tong Z et al.
Journal of Translational Medicine, 2021
Variants of Lipid-Related Genes in Adult Japanese Patients with Severe Hypertriglyceridemia.
Matsunaga A et al.
Journal of Atherosclerosis and Thrombosis, 2020
Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease.
Biterova E et al.
Scientific Reports, 2018
ANGPTL4 variants and their haplotypes are associated with serum lipid levels, the risk of coronary artery disease and ischemic stroke and atorvastatin cholesterol-lowering responses.
Yang Q et al.
Nutrition & Metabolism, 2018
ANGPTL4 T266M variant is associated with reduced cancer invasiveness.
Tan ZW et al.
Biochimica Et Biophysica Acta. Molecular Cell Research, 2017
Uncovering Local Trends in Genetic Effects of Multiple Phenotypes via Functional Linear Models.
Vsevolozhskaya OA et al.
Genetic Epidemiology, 2016
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
Stitziel NO et al.
The New England Journal of Medicine, 2016
ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in Type 2 diabetic Tunisian population.
Abid K et al.
Lipids in Health and Disease, 2016
Angiopoietin-like protein 4 serum levels and gene polymorphisms are associated with large artery atherosclerotic stroke.
He XW et al.
Journal of the Neurological Sciences, 2016
Update on the molecular biology of dyslipidemias.
Ramasamy I
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2016
Single Nucleotide Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome.
Suvanto M et al.
International Journal of Nephrology, 2016
Angiopoietin-like protein 4 significantly predicts future cardiovascular events in coronary patients.
Muendlein A et al.
Atherosclerosis, 2014
AKT3, ANGPTL4, eNOS3, and VEGFA associations with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau.
Buroker NE et al.
International Journal of Hematology, 2012
ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial.
Smart-Halajko MC et al.
Bmc Medical Genetics, 2011
Angiopoietin-like 4 (ANGPTL4) gene polymorphisms and risk of brain arteriovenous malformations.
Mikhak B et al.
Cerebrovascular Diseases (basel, Switzerland), 2011
The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk.
Smart-Halajko MC et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2010
Phylogenetics applied to genotype/phenotype association and selection analyses with sequence data from angptl4 in humans.
Maxwell TJ et al.
International Journal of Molecular Sciences, 2010
Associations between common genetic polymorphisms in angiopoietin-like proteins 3 and 4 and lipid metabolism and adiposity in European adolescents and adults.
Legry V et al.
The Journal of Clinical Endocrinology and Metabolism, 2009
ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk.
Talmud PJ et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2008
Genetic variation within the ANGPTL4 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus.
Staiger H et al.
Metabolism: Clinical and Experimental, 2008
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing.
Cefalù AB et al.
Journal of Clinical Lipidology, 0